A rare association of Sweet syndrome in a diagnosed case of pemphigus vulgaris

Authors

  • Afshan Ahmad Lahore General Hospital, Lahore
  • Hina Manzoor Lahore General Hospital, Lahore
  • Hashim Sagheer Lahore General Hospital, Lahore
  • Madiha Sanai Lahore General Hospital
  • Hina Manzoor Lahore General Hospital, Lahore
  • Maria Azad Lahore General Hospital, Lahore
  • Aneela Asghar Lahore General Hospital, Lahore

DOI:

https://doi.org/10.66344/jpad.34.1.2024.2539

Keywords:

Sweet Syndrome, Pemphigus vulgaris., Neutrophilic dermatosis

Abstract

Sweet syndrome (SS) is a rare neutrophilic dermatosis. It is characterized by acute onset of fever and painful erythematous papules, plaques and nodule on skin. SS may affect other organs. Pemphigus Vulgaris is an immune mediated condition which is characterized by the flaccid blisters affecting mainly trunk and mucosae with painful erosions. A 59 years old male, diagnosed case of Diabetes Mellitus and Pemphigus vulgaris, presented to our outpatient department with fever and multiple painful erythematous plaques, nodules and ulcers on both lower limbs. He was in remission phase of pemphigus vulgaris with immunosuppressants namely steroids and azathioprine. Patient fulfilled diagnostic criteria of Sweet syndrome. During his stay in the department of dermatology, he developed neurological manifestations in the form of weakness of the left proximal upper limb with altered sensorium. Cerebrovascular infarct was confirmed on computed tomography (CT) scan. Cerebrovascular infarct is a very rare manifestation of neuro-Sweet disease. SS is associated with many conditions. It is reported in various autoimmune conditions. But as far as pemphigus vulgaris is concerned SS is reported very rarely with pemphigus vulgaris

References

References

Ma M, Wei S, Yin D, Li W, Li C. A Case of Neutrophilic Dermatoses-Sweet's Syndrome Coexisting with SAPHO Syndrome. Clin Cosmet Investig Dermatol. 2023 Mar 27;16:739-742.

Joshi TP, Friske SK, Hsiou DA, Duvic M. New Practical Aspects of Sweet Syndrome. Am J Clin Dermatol. 2022 May;23(3):301-318.

Ramirez Melo JL, Cruz Osorio RM, Santoyo Cueva J, Sanchez Zubieta F, Chavez PA, Fernandez Mendoza LT, Bustos Rodriguez FJ, Burbano Figueroa CD, Burbano Figueroa JA. Sweet Syndrome in an Adolescent Patient With Differentiation Syndrome Secondary to Promyelocytic Leukemia Treatment With All-Trans Retinoic Acid. J Med Cases. 2021 Dec;12(12):469-473.

Burke N, Saikaly SK, Motaparthi K, Bender NR. Malignancy-associated Sweet syndrome presenting with simultaneous histopathologic and morphologic variants. JAAD Case Rep. 2021 Jun 17;14:104-107.

Batubara IS, Novianto E, Rihatmadja R, Budianti WK, Fitri EM, Debinta AA et al. A rare case of pemphigus vulgaris in pregnancy: Challenge in management. Journal of Pakistan Association of Dermatologists. 2022 Jan;32(1):178-182.

del Pozo J, Martínez W, Carro E, Arévalo MP, Rodríguez-Lozano J, Fonseca E. A case of Sweet's syndrome and pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2004 Nov;18(6):745-6.

O'Toole A, O'Malley M. Sweet syndrome and pemphigus vulgaris. J Cutan Med Surg. 2012 Mar-Apr;16(2):128-30.

Published

2024-05-06

How to Cite

1.
Ahmad A, Manzoor H, Sagheer H, Sanai M, Manzoor H, Azad M, Asghar A. A rare association of Sweet syndrome in a diagnosed case of pemphigus vulgaris. J Pak Assoc Dermatol [Internet]. 2024May6 [cited 2026Apr.11];34(1):286-9. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2539

Issue

Vol. 34 No. 1 (2024): January-March

Section

Case Reports

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.